Reframing perineural invasion in intrahepatic cholangiocarcinoma as a spatial neuroimmune niche
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-11 · 1881 (6) · 189747
DOI: 10.1016/j.bbcan.2026.189747 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-11. Verfasst von Xin Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Pancreato-biliary Surgery, The People's Hospital of Leshan, Leshan, China; Laboratory of Hepatic AI Translation, Frontiers Scien…. Die Arbeit nennt 132 Literaturangaben.
Abstract (Originalsprache)
Perineural invasion (PNI) is an adverse histopathological feature in intrahepatic cholangiocarcinoma (iCCA), yet its biological meaning is often reduced to a binary pathology variable. This convention overlooks the spatial heterogeneity of the tumour-nerve interface, where nerve subtype, tumour-nerve geometry, stromal organization and immune-cell positioning may carry distinct clinical implications. Recent iCCA-specific evidence identifies, in selected PNI-positive tumours, TH-positive sympathetic fibres, increased norepinephrine, tumour-cell ADRB2-PI3K-AKT-NF-κB-MDK signalling and ferroptosis-associated dysfunction of CD56dimCD16+ natural killer cells. This is currently the strongest disease-specific neuroimmune axis, but it represents only one component of a broader niche that may include CD8+ T-cell exclusion or exhaustion, regulatory and helper T-cell states, macrophage/MDSC suppression, CAF/ECM barriers and TLS topology. In this Review, we distinguish direct iCCA or iCCA-PNI evidence from evidence from other CCA subtypes or general iCCA studies and from cross-cancer hypotheses. We propose a candidate, unvalidated spatial neuroimmune framework that integrates neural phenotyping, spatial immune mapping and imaging. The framework is intended to support four separate research uses-prognostic stratification, preoperative prediction of pathological PNI, pharmacodynamic monitoring and prospective treatment-benefit testing-and should not be treated as a validated clinical score or as a basis for unselected neural or immune therapy. This approach may move PNI reporting from a binary risk label toward a testable, spatially resolved model of iCCA heterogeneity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepato-Pancreato-biliary Surgery, The People's Hospital of Leshan, Leshan, China; Laboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital,…
- Department of Hepato-Pancreato-biliary Surgery, The People's Hospital of Leshan, Leshan, China.
- Laboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China; Liver Transplant Center, Transplant Center, West China Hospi…
Zitieren
APA
Zhao, X., Liu, Z., Yang, J., Jiang, K., & Gao, F. (2026). Reframing perineural invasion in intrahepatic cholangiocarcinoma as a spatial neuroimmune niche. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(6), 189747. https://doi.org/10.1016/j.bbcan.2026.189747
Vancouver
Zhao X, Liu Z, Yang J, Jiang K, Gao F. Reframing perineural invasion in intrahepatic cholangiocarcinoma as a spatial neuroimmune niche. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(6):189747. doi:10.1016/j.bbcan.2026.189747
BibTeX
@article{Zhao2026,
author = {Zhao, Xin and Liu, Zhuoran and Yang, Jie and Jiang, Kangyi and Gao, Fengwei},
title = {Reframing perineural invasion in intrahepatic cholangiocarcinoma as a spatial neuroimmune niche},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {6},
pages = {189747},
doi = {10.1016/j.bbcan.2026.189747}
}
EUVIMED